Abstract
Efflux-pump system and biofilm formation are two important mechanisms Pseudomonas aeruginosa deploys to escape the effects of antibiotics. The current study was undertaken from September 2019 to March 2020 at a tertiary-care hospital in Kathmandu in order to ascertain the burden of P. aeruginosa in clinical specimens, examine their biofilm-forming ability and determine their antibiotic susceptibility pattern along with the possession of two efflux-pump genes-mexA and mexB. Altogether 2820 clinical specimens were collected aseptically from the patients attending the hospital and processed according to standard microbiological procedures. Identification of P. aeruginosa was done by Gram stain microscopy and an array of biochemical tests. All the P. aeruginosa isolates were subjected to in vitro antibiotic susceptibility testing and their biofilm-forming ability was also examined. Presence of mexA and mexB efflux-pump genes was analyzed by Polymerase Chain Reaction (PCR) using specific primers. Out of 603 culture positive isolates, 31 (5.14%) were found to be P. aeruginosa, of which 55% were multi-drug resistant (MDR). Out of 13 commonly used antibiotics tested by Kirby-Bauer disc diffusion method, greatest resistance was shown against piperacillin-tazobactam 15 (48.4%) and ceftazidime 15 (48.4%), and least against meropenem 6 (19.4%) and ofloxacin 5 (16.2%). Of all 17 MDR isolates subjected to biofilm detection, strong biofilm formation was exhibited by 11 (65%) and 14 (82%) isolates with microtiter plate method and tube method respectively. Out of 17 isolates tested, 12 (70.6%) isolates possessed mexA and mexB genes indicating the presence of active efflux-pump system. Higher number of the isolates recovered from sputum 7 (58.3%) and pus 5 (41.7%) possessed mexA/mexB genes while the genes were not detected at all in the isolates recovered from the urine (p<0.05). This study assessed no significant association between biofilm production and multi-drug resistance (p>0.05). Adoption of stern measures by the concerned authorities to curb the incidence of multi-drug resistant and biofilm-forming isolates is recommended to prevent their dissemination in the hospital settings.
Highlights
Pseudomonas aeruginosa is extensively spread opportunistic human pathogen associated with numerous acute and chronic human infections, such as respiratory and urinary tract infection, pneumonia and bacteremia [1]
The number of transmembrane spanning regions, energy sources and substrates, bacterial efflux pumps is classified into six families: ATP-binding cassette (ABC) superfamily, the small multidrug resistance (SMR) family, the major facilitator superfamily (MFS), the resistance-nodulationdivision (RND) superfamily, the drug metabolite transporter (DMT) superfamily and the multidrug and toxic compound extrusion (MATE) family [9, 10]
P. aeruginosa has a significant number of efflux pumps, including four potent RND-type multidrug resistance efflux pumps (Mex) that remove harmful chemicals from the periplasm and cytoplasm [6]
Summary
Pseudomonas aeruginosa is extensively spread opportunistic human pathogen associated with numerous acute and chronic human infections, such as respiratory and urinary tract infection, pneumonia and bacteremia [1]. It can thrive in a broad range of different natural and artificial environments including medical surfaces, due to its suitability and its strong intrinsic antibiotic resistance [2, 3]. The MexAB-oprM efflux pump system was reported to contribute in conferring inherent resistance to chloramphenicol, b-lactams, quinolones, macrolides novobiocin and tetracyclines [11] Overproduction of such types of efflux systems plays a significant role in development of multidrug-resistant (MDR) bacteria [12]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
